| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
14,310,000 |
| Market
Cap: |
9.45(M) |
| Last
Volume: |
26,960 |
Avg
Vol: |
26,885 |
| 52
Week Range: |
$0.5651 - $1.28 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for rare and life-threatening diseases. Co.'s pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; ACER-801 (osanetant) for the treatment of induced vasomotor symptoms; EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome in patients with a confirmed type III collagen mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,229,508 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,500,000 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Seaman Scott B |
Director |
• • – |
2015-04-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
518,707 |
1,037,414 |
|
- |
|
| Seaman Scott B |
Director |
• • – |
2015-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,087 |
85,000 |
|
- |
|
| Radhakrishnan Karthik |
Chief Financial Officer |
• • – |
2015-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
124,659 |
|
- |
|
| Richman Michael |
Director |
• • – |
2015-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,242 |
23,302 |
|
- |
|
| Barabe Timothy C |
Director |
• • – |
2015-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
38,818 |
|
- |
|
| Maderis Gail J |
Director |
• • – |
2015-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,242 |
23,302 |
|
- |
|
| Maderis Gail J |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,818 |
15,060 |
|
- |
|
| Richman Michael |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,818 |
15,060 |
|
- |
|
| Barabe Timothy C |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,818 |
22,818 |
|
- |
|
| Barabe Timothy C |
Director |
– • – |
2014-09-17 |
4 |
B |
$1.15 |
$11,500 |
D/D |
10,000 |
16,000 |
2.39 |
- |
|
| Warma Neil K |
President & CEO |
• • – |
2014-09-16 |
4 |
B |
$1.11 |
$11,100 |
D/D |
10,000 |
107,634 |
2.81 |
- |
|
61 Records found
|
|
Page 3 of 3 |
|
|
